Evidence map›Paper›PMID 31534168›Full record

ArticleScientific reports2019

Oxidative stress-responsive apoptosis inducing protein (ORAIP) plays a critical role in cerebral ischemia/reperfusion injury.

Masao Kishimoto, Jun Suenaga, Hajime Takase, Kota Araki, Takako Yao, Tsutomu Fujimura, Kimie Murayama, Ko Okumura, Ryu Ueno, Nobuyuki Shimizu and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. [Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Life (Basel, Switzerland) · 2024
    Article
  9. Article
  10. Brush strokes on MRI.European radiology · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2022
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Masao KishimotoDepartment of Neurosurgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Jun SuenagaDepartment of Neurosurgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan. suenaga@yokohama-cu.ac.jp.
Hajime TakaseDepartment of Neurosurgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Kota ArakiDepartment of Neurosurgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Takako YaoDivision of Cardiovascular Medicine, The Institute for Adult Diseases, Asahi Life Foundation, Tokyo, Japan.
Tsutomu FujimuraLaboratory of Bioanalytical Chemistry, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Kimie MurayamaDivision of Proteomics and Biomolecular Science, BioMedical Research Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Ko OkumuraDepartment of Biofunctional Microbiota, Juntendo University School of Medicine, Tokyo, Japan.
Ryu UenoDepartment of Neurosurgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Nobuyuki ShimizuDepartment of Neurosurgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Nobutaka KawaharaDepartment of Neurosurgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Tetsuya YamamotoDepartment of Neurosurgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Yoshinori SekoDepartment of Biofunctional Microbiota, Juntendo University School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0002-6646-4743
Yokohama City University · JPJuntendo University · JPThe Institute of Medical Science, Asahi Life Foundation · JPTohoku Medical and Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress is known to play a critical role in the pathogenesis of various disorders, especially in ischemia/reperfusion (I/R) injury. We identified an apoptosis-inducing humoral factor and named this novel post translationally modified secreted form of eukaryotic translation initiation factor 5A (eIF5A) "oxidative stress-responsive apoptosis inducing protein" (ORAIP). The purpose of this study was to investigate the role of ORAIP in the mechanisms of cerebral I/R injury. Hypoxia/reoxygenation induced expression of ORAIP in cultured rat cerebral neurons, resulting in extensive apoptosis of these cells, which was largely suppressed by neutralizing anti-ORAIP monoclonal antibody (mAb) in vitro. Recombinant-ORAIP induced extensive apoptosis of cerebral neurons. Cerebral I/R induced expression of ORAIP in many neurons in a rat tandem occlusion model in vivo. In addition, we analyzed the effects of intracerebroventricular administration of neutralizing anti-ORAIP mAb on the development of cerebral infarction. Cerebral I/R significantly increased ORAIP levels in cerebrospinal fluid. Treatment with intracerebroventricular administration of neutralizing anti-ORAIP mAb reduced infarct volume by 72%, and by 55% even when started after reperfusion. These data strongly suggest that ORAIP plays a pivotal role and will offer a critical therapeutic target for cerebral I/R injury induced by thrombolysis and thrombectomy for acute ischemic stroke.

Indexed as

AnimalsApoptosisApoptosis Regulatory ProteinsBrain IschemiaCell HypoxiaEukaryotic Translation Initiation Factor 5AInfarction, Middle Cerebral ArteryMaleNeuronsOxidative StressPeptide Initiation FactorsRatsRats, Inbred SHRReperfusion InjuryRNA-Binding ProteinsStrokeApoptosis Regulatory ProteinsEukaryotic Translation Initiation Factor 5APeptide Initiation FactorsRNA-Binding Proteins

Identifiers

PMID31534168
PMCPMC6751213
OpenAlexW2974311262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.